SAHPRA issues warning on the rise of sales of counterfeit Ozempic
Zuko Komisa Image | Adobe Stock Ozempic and other fake Glucagon-like Peptide (GLP-1) items are becoming more and more common on the local market, which has alarmed the South African Health items Regulatory Authority (SAHPRA). A rise in suspected counterfeit Ozempic, also known as semaglutide, a registered medicine from Novo Nordisk that contains GLP-1 agonists, has been detected by SAHPRA. In South Africa, Ozempic is registered under two types of […]